There May Be a New First-Line Treatment for Depression

There May Be a New First-Line Treatment for Depression

Source: 
Motley Fool
snippet: 

This year, Axsome Therapeutics (NASDAQ:AXSM) will be filing a New Drug Application for a novel therapy to treat depression. For millions of adults with depression worldwide, the drug candidate may rapidly replace traditional standards of care.